当前位置:首页 - 行情中心 - 春立医疗(688236) - 财务分析 - 现金流量表

春立医疗

(688236)

  

流通市值:82.95亿  总市值:110.31亿
流通股本:2.88亿   总股本:3.84亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金787,304,954.6565,945,760.08154,928,044.7898,017,108.57
  收到的税费返还2,825,763.952,729,410.74-12,079,193.04
  收到其他与经营活动有关的现金15,765,417.6311,886,857.735,079,610.4344,382,434.75
  经营活动现金流入小计805,896,136.18580,562,028.55160,007,655.13954,478,736.36
  购买商品、接受劳务支付的现金298,567,305.53200,241,512.11118,196,154.09357,543,776.96
  支付给职工以及为职工支付的现金149,971,256.13110,009,221.4556,582,807.71246,954,981.06
  支付的各项税费29,932,778.514,727,332.1510,570,701.9675,353,479.95
  支付其他与经营活动有关的现金152,857,751.91114,097,579.7450,001,576.97276,526,049.32
  经营活动现金流出小计631,329,092.07439,075,645.45235,351,240.73956,378,287.29
  经营活动产生的现金流量净额174,567,044.11141,486,383.1-75,343,585.6-1,899,550.93
二、投资活动产生的现金流量:
  收回投资收到的现金744,000,000744,000,000744,000,0002,330,000,000
  取得投资收益收到的现金6,619,109.046,619,109.046,619,109.0420,636,632.87
  处置固定资产、无形资产和其他长期资产收回的现金净额23,00023,000-21,000
  投资活动现金流入小计750,642,109.04750,642,109.04750,619,109.042,350,657,632.87
  购建固定资产、无形资产和其他长期资产支付的现金48,492,401.8330,116,695.8618,309,973.6949,171,760.26
  投资支付的现金880,000,000860,000,000-2,244,000,000
  取得子公司及其他营业单位支付的现金2,200,0002,200,000-1,650,000
  投资活动现金流出小计930,692,401.83892,316,695.8618,309,973.692,294,821,760.26
  投资活动产生的现金流量净额-180,050,292.79-141,674,586.82732,309,135.3555,835,872.61
三、筹资活动产生的现金流量:
  分配股利、利润或偿付利息支付的现金18,727,390.8--170,533,715.46
  支付其他与筹资活动有关的现金8,656,570.638,618,899.6335,877.1412,605,553.29
  筹资活动现金流出小计27,383,961.438,618,899.6335,877.14183,139,268.75
  筹资活动产生的现金流量净额-27,383,961.43-8,618,899.63-35,877.14-183,139,268.75
四、汇率变动对现金及现金等价物的影响-248,760.77-275,701.1887,041.012,207,522.06
五、现金及现金等价物净增加额-33,115,970.88-9,082,804.53657,016,713.62-126,995,425.01
  加:期初现金及现金等价物余额1,139,017,650.661,139,017,650.661,139,017,650.661,266,013,075.67
  期末现金及现金等价物余额1,105,901,679.781,129,934,846.131,796,034,364.281,139,017,650.66
补充资料:
  净利润-114,481,155.04-124,661,283.5
  资产减值准备-26,911,765.98-33,776,793.41
  固定资产和投资性房地产折旧-13,300,195.1-25,962,979.19
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-13,300,195.1-25,962,979.19
  无形资产摊销-6,376,890.11-10,914,440.37
  处置固定资产、无形资产和其他长期资产的损失--3,848.03--39,213.61
  公允价值变动损失--4,296,252.04--9,434,830.14
  财务费用-287,993.88--2,162,582.99
  投资损失--3,217,026.86--10,980,482.17
  递延所得税--3,284,665.23-2,900,211.92
  其中:递延所得税资产减少--4,036,046.42-1,518,832.25
    递延所得税负债增加-751,381.19-1,381,379.67
  存货的减少--38,635,181.65--136,774,192.51
  经营性应收项目的减少-87,729,121.24-63,203,573.41
  经营性应付项目的增加--70,916,603.28--108,913,625.87
  现金的期末余额-1,129,934,846.13-1,139,017,650.66
  减:现金的期初余额-1,139,017,650.66-1,266,013,075.67
  现金及现金等价物的净增加额--9,082,804.53--126,995,425.01
公告日期2025-10-312025-08-302025-04-302025-03-29
审计意见(境内)标准无保留意见
TOP↑